Does inhaled nitric oxide treatment of pulmonary hypertension in extremely premature infants improve patient outcomes?

QUESTIONDoes inhaled nitric oxide (iNO) treatment for early echocardiographic pulmonary hypertension (PH) decrease the risk of death or bronchopulmonary dysplasia (BPD) in extremely preterm infants? METHODS DesignSingle-center double-blinded randomized control trial (RCT). PatientsInfants born less than or equal to 29 weeks' gestation who received positive pressure ventilation at 72 24 postnatal hours were eligible.